BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 34109612)

  • 1. Superior outcome for splenectomised patients in a population-based study of splenic marginal zone lymphoma in Sweden.
    Sima A; Hollander P; Baecklund E; Smedby KE; Enblad G; Amini RM
    Br J Haematol; 2021 Aug; 194(3):568-579. PubMed ID: 34109612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk-tailored treatment of splenic marginal zone lymphoma.
    Castelli R; Balzarotti M; Salvi E; Simona Rossi R; Lambertenghi Deliliers G; Bergamaschini L; Gidaro A
    Anticancer Drugs; 2022 Jan; 33(1):e36-e42. PubMed ID: 34407041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laparoscopic splenectomy for treatment of splenic marginal zone lymphoma.
    Wu Z; Zhou J; Wang X; Li YB; Niu T; Peng B
    World J Gastroenterol; 2013 Jun; 19(24):3854-60. PubMed ID: 23840125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Splenic marginal zone lymphoma associated with hepatitis B virus infection, remission after viral treatment, and splenectomy: A case report and review of the literature.
    Ababou M; Mahtat EM; Jennane S; Elmaaroufi H; Mikdame M; Doghmi K
    Hematol Oncol Stem Cell Ther; 2021 Jun; 14(2):153-155. PubMed ID: 31306619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Splenic marginal zone lymphoma: from genetics to management.
    Arcaini L; Rossi D; Paulli M
    Blood; 2016 Apr; 127(17):2072-81. PubMed ID: 26989207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Splenic Marginal Zone Lymphoma in Turkey: Association with Hepatitis B Instead of Hepatitis C Virus as an Etiologic and Possible Prognostic Factor - A Multicenter Cohort Study.
    Okay M; Aslan T; Özdemir E; Üner A; Sağlam A; Güngör E; Uysal A; Alayvaz Aslan N; Yıldızhan E; Ağıt A; Dal MS; Korkmaz S; Namdaroğlu S; Sivgin S; Akgün Çağlıyan G; Demircioğlu S; Barışta İ; Özhamam E; Vural F; Eser B; Özet G; Yıldırım R; Doğu MH; Berber İ; Erkurt MA; Malkan ÜY; Altuntaş F; Büyükaşık Y
    Turk J Haematol; 2020 May; 37(2):84-90. PubMed ID: 31630512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of splenic marginal zone lymphoma: should splenectomy be abandoned?
    Kalpadakis C; Pangalis GA; Vassilakopoulos TP; Sachanas S; Angelopoulou MK
    Leuk Lymphoma; 2014 Jul; 55(7):1463-70. PubMed ID: 24050506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Still a role for surgery as first-line therapy of splenic marginal zone lymphoma? Results of a prospective observational study.
    Pata G; Bartoli M; Damiani E; Solari S; Anastasia A; Pagani C; Tucci A
    Int J Surg; 2017 May; 41():143-149. PubMed ID: 28366762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinico-biological features and outcome of patients with splenic marginal zone lymphoma with histological transformation.
    Bastidas-Mora G; Beà S; Navarro A; Gine E; Costa D; Delgado J; Baumann T; Magnano L; Rivas-Delgado A; Villamor N; Colomer D; Lopez-Guerra M; Rozman M; Balagué O; Martínez D; Baptista MJ; Escoda L; Alcoceba M; Blanes M; Climent F; Campo E; Wotherspoon A; López-Guillermo A; Matutes E
    Br J Haematol; 2022 Jan; 196(1):146-155. PubMed ID: 34519021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term follow-up analysis of 100 patients with splenic marginal zone lymphoma treated with splenectomy as first-line treatment.
    Lenglet J; Traullé C; Mounier N; Benet C; Munoz-Bongrand N; Amorin S; Noguera ME; Traverse-Glehen A; Ffrench M; Baseggio L; Felman P; Callet-Bauchu E; Brice P; Berger F; Salles G; Brière J; Coiffier B; Thieblemont C
    Leuk Lymphoma; 2014 Aug; 55(8):1854-60. PubMed ID: 24206091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time Trend Analysis of Splenectomy for Splenic Marginal Zone Lymphoma: Declining Surgery, Promising Survival.
    Yang Z; Liu L; Leng K; Shi G
    Ann Surg Oncol; 2023 Nov; 30(12):7206-7216. PubMed ID: 37516724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complete remission of splenic marginal zone lymphoma after an acute flare-up of hepatitis B in a hepatitis B virus carrier.
    Fujimoto K; Endo T; Nishio M; Obara M; Yamaguchi K; Takeda Y; Goto H; Kasahara I; Sato N; Koike T
    Int J Hematol; 2009 Dec; 90(5):601-604. PubMed ID: 19802732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Splenic marginal zone lymphoma: a case report and literature review.
    Zhang S; Xuan Z; Zhang L; Lu J; Song P; Zheng S
    World J Surg Oncol; 2020 Oct; 18(1):259. PubMed ID: 33004051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival outcomes with and without splenectomy in splenic marginal zone lymphoma.
    Olszewski AJ
    Am J Hematol; 2012 Nov; 87(11):E119-22. PubMed ID: 22887176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative outcomes of rituximab-based systemic therapy and splenectomy in splenic marginal zone lymphoma.
    Olszewski AJ; Ali S
    Ann Hematol; 2014 Mar; 93(3):449-58. PubMed ID: 24057925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early-stage splenic diffuse large B-cell lymphoma is highly associated with hepatitis C virus infection.
    Yu SC; Lin CW
    Kaohsiung J Med Sci; 2013 Mar; 29(3):150-6. PubMed ID: 23465418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Characteristics, Treatment and Evolution of Splenic and Nodal Marginal Zone Lymphomas-Retrospective and Multicentric Analysis of Portuguese Centers.
    Rodrigues CD; Peixeiro RP; Viegas D; Chorão P; Couto ME; Gaspar CL; Fernandes JP; Alves D; Ribeiro LA; de Vasconcelos M P; Tomé AL; Badior M; Coelho H; Príncipe F; Chacim S; da Silva MG; Coutinho R
    Clin Lymphoma Myeloma Leuk; 2021 Nov; 21(11):e839-e844. PubMed ID: 34326035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C virus infection and locally advanced splenic marginal zone lymphoma.
    Szynglarewicz B; Matkowski R; Smorag Z; Forgacz J; Pudelko M; Kornafel J
    Pathol Oncol Res; 2007; 13(4):382-4. PubMed ID: 18158578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes in splenic marginal zone lymphoma: analysis of 107 patients treated in British Columbia.
    Xing KH; Kahlon A; Skinnider BF; Connors JM; Gascoyne RD; Sehn LH; Savage KJ; Slack GW; Shenkier TN; Klasa R; Gerrie AS; Villa D
    Br J Haematol; 2015 May; 169(4):520-7. PubMed ID: 25854936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological features of splenic tumours of lymphoid tissue.
    Chen DB; Shen DH; Yang SM; Fang XZ
    Pathol Res Pract; 2018 Dec; 214(12):1952-1958. PubMed ID: 30087035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.